Erythema multiforme with reference to atypical presentation in an HIV-positive patient following antiretroviral therapy discontinuation

Acta Dermatovenerologica Croatica

Volumn 17, Issue 1, 2009, Pages 9-15

  Mihić, Liborija Lugović ^a   Buljan, Marija ^a   Bulat, Vedrana ^a   Šitum, Mirna ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Erythema multiforme; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIHISTAMINIC AGENT; AZITHROMYCIN; CORTICOSTEROID; DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; TERBINAFINE;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHEMA MULTIFORME; FEMALE; HERPES SIMPLEX; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; ISCHIALGIA; LABORATORY TEST; MALE; ONYCHOMYCOSIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; STEVENS JOHNSON SYNDROME;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; ERYTHEMA MULTIFORME; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 65749090387     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. nd Edition. New York: Churchill Livingstone; 1996. pp. 483-490
2. nd Edition, Completely Revised Edition. Berlin: Springer; 2000. pp. 414-6; 579-82.
3. Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 1983;8:763-775
4. nd Edition. Boston: Hanley and Belfus, Inc; 2001. pp. 93-94; 428-9.
5. von Hebra F. On Diseases of the Skin Including Exanthemata. Translated by CH Fagge Vol. 1. London: New Sydenham Society; 1866. pp. 285-289
6. Stevens AM, Johnson FC. A new eruptive fever associated with stomatitis and ophthalmia. Am J Dis Child 1922;24:526-533
7. Lyell A. A review of toxic epidermal necrolysis in Britain. Br J Dermatol 1967;79:662-671
8. Howland WH, Golitz LE, Huff JC, Weston WL. Erythema multiforme: clinical, pathologic, and immunologic studies. J Am Acad Dermatol 1984;10:438-446
9. Zaim MT, Giorno RC, Golitz LE, Kunke KS, Huff JC. An immunopathologic study of herpes-associated erythema multiforme. J Cutan Pathol 1987;14:257-262
10. Orton PW, Huff JC, Tonnesen MG, Weston WL. Detection of herpes simplex virus antigens in skin lesions of erythema multiforme. Ann Intern Med 1984;101:48-50.
11. Brice SL, Krzemien D, Weston WL, Huff JC. Detection of HSV DNA in cutaneous lesions of erythema multiforme. J Invest Dermatol 1989;193:183-187
12. Schofield JK, Tatnall FM, Brown J, McCloskey D, Navarrete C, Leigh IM. Recurrent erythema multiforme: tissue typing in a large series of patients. Br J Dermatol 1994;131:532-535
13. Sontheimer RD, Garibaldi RA, Krueger GG. Stevens-Johnson syndrome with Mycoplasma pneumoniae infections. Arch Dermatol 1978;114:241-244
14. nd Edition. Philadelphia: WB Saunders Company; 1998. p. 61.
15. Auquier-Dunant A, Mockanhaupt M, Naldi L, Correia O, Schroder W, Roujeu JC. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and TEN: results of an international prospective study. Arch Dermatol 2002;138:1019-1024
16. Bulat V, Lugović L, Šitum M. Prominent features and variations in clinical presentation of erythema multiforme. Acta Clin Croat 2007;46:55-62.
17. Rotunda A, Hirsch RJ, Scheinfeld N, Weinberg JM. Severe cutaneous reactions associated with the use of human immunodeficiency virus medications. Acta Derm Venerol 2003;83:1-9.